Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karen E Duff

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Trends in Molecular Medicine|December 14, 2017
Targeting the 26S Proteasome To Protect Against Proteotoxic DiseasesNatura Myeku, Karen E Duff
Nature Medicine|August 13, 2021
Tau-targeting antibody therapies: too late, wrong epitope or wrong target?Edwin Jabbari, Karen E Duff
Ebiomedicine|February 1, 2025
Synapse vulnerability and resilience underlying Alzheimer's diseaseRaquel N Taddei, Karen E Duff
Nature Reviews. Neurology|May 22, 2025
Synapse vulnerability and resilience across the clinical spectrum of dementiasRaquel N Taddei, Karen E Duff
Journal of Alzheimer'S Disease : JAD|August 9, 2008
Is tau aggregation toxic or protective?Erin E Congdon, Karen E Duff
Nature Neuroscience|September 26, 2018
Selective vulnerability in neurodegenerative diseasesHongjun Fu, John Hardy, Karen E Duff
Neurobiology of Disease|November 15, 2011
Microarray analysis of CA1 pyramidal neurons in a mouse model of tauopathy reveals progressive synaptic dysfunctionMelissa J Alldred, Karen E Duff, Stephen D Ginsberg
Neurochemical Research|May 20, 2017
Progressive Pathological Changes in Neurochemical Profile of the Hippocampus and Early Changes in the Olfactory Bulbs of Tau Transgenic Mice (rTg4510)Jieun Kim, In-Young Choi, Karen E Duff, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Basic Science and PathogenesisKaren E Duff, Mathieu Bourdenx, Paula Maglio Cauhy, et al.
JAMA Neurology|April 20, 2013
Mechanisms of protein seeding in neurodegenerative diseasesLary C Walker, Marc I Diamond, Karen E Duff, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Trends in Molecular Medicine|December 14, 2017
Targeting the 26S Proteasome To Protect Against Proteotoxic DiseasesNatura Myeku, Karen E Duff
Nature Medicine|August 13, 2021
Tau-targeting antibody therapies: too late, wrong epitope or wrong target?Edwin Jabbari, Karen E Duff
Ebiomedicine|February 1, 2025
Synapse vulnerability and resilience underlying Alzheimer's diseaseRaquel N Taddei, Karen E Duff
Nature Reviews. Neurology|May 22, 2025
Synapse vulnerability and resilience across the clinical spectrum of dementiasRaquel N Taddei, Karen E Duff
Journal of Alzheimer'S Disease : JAD|August 9, 2008
Is tau aggregation toxic or protective?Erin E Congdon, Karen E Duff
Nature Neuroscience|September 26, 2018
Selective vulnerability in neurodegenerative diseasesHongjun Fu, John Hardy, Karen E Duff
Neurobiology of Disease|November 15, 2011
Microarray analysis of CA1 pyramidal neurons in a mouse model of tauopathy reveals progressive synaptic dysfunctionMelissa J Alldred, Karen E Duff, Stephen D Ginsberg
Neurochemical Research|May 20, 2017
Progressive Pathological Changes in Neurochemical Profile of the Hippocampus and Early Changes in the Olfactory Bulbs of Tau Transgenic Mice (rTg4510)Jieun Kim, In-Young Choi, Karen E Duff, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Basic Science and PathogenesisKaren E Duff, Mathieu Bourdenx, Paula Maglio Cauhy, et al.
JAMA Neurology|April 20, 2013
Mechanisms of protein seeding in neurodegenerative diseasesLary C Walker, Marc I Diamond, Karen E Duff, et al.
Pageof 6